A Phase II Study of 9-Nitro-Camptothecin in Patients with Previously Treated Metastatic Breast Cancer

By Miller Kathy D.   Soule Sharon E.   Haney LaTrice G.   Guiney Patricia   Murry Darryl J.   Lenaz Luigi   Sun Show-Li   Sledge Jr George W.  

Investigational New Drugs, Vol. 22, Iss. 1, 2004-01 ,pp. : 69-73

Springer Publishing Company

Access to resources Recommend Favorite

A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxane

By Ajani J.   Safran H.   Bokemeyer C.   Shah M.   Lenz H.-J.   Cutsem E.   Burris H.   Lebwohl D.   Mullaney B.  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 441-446

Springer Publishing Company

Access to resources Recommend Favorite

A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma

By Ajani Jaffer   Jiang Yixing   Faust Josephine   Chang Baochong   Ho Linus   Yao James   Rousey Steven   Dakhil Shaker   Cherny Richard   Craig Catherine   Bleyer Archie  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 353-357

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant Treatment with Paclitaxel and Epirubicin in Invasive Breast Cancer: A Phase II Study

By Sarid David  

Clinical Drug Investigation, Vol. 26, Iss. 12, 2006-01 ,pp. : 691-701

Adis International

Access to resources Recommend Favorite

A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial

By Knowling M.   Blackstein M.   Tozer R.   Bramwell V.   Dancey J.   Dore N.   Matthews S.   Eisenhauer E.  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 435-439

Springer Publishing Company

Access to resources Recommend Favorite